AstraZeneca Share Forecast, Price & News

AstraZeneca (LON:AZN) Frequently Asked Questions

Is AstraZeneca a buy right now?

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AstraZeneca stock.
View analyst ratings for AstraZeneca or view top-rated stocks.

What stocks does MarketBeat like better than AstraZeneca?

Wall Street analysts have given AstraZeneca a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AstraZeneca wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is AstraZeneca's next earnings date?

AstraZeneca is scheduled to release its next quarterly earnings announcement on Friday, November 12th 2021.
View our earnings forecast for AstraZeneca.

How has AstraZeneca's stock been impacted by COVID-19 (Coronavirus)?

AstraZeneca's stock was trading at GBX 6,955 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AZN stock has increased by 26.1% and is now trading at GBX 8,768.
View which stocks have been most impacted by COVID-19.

How often does AstraZeneca pay dividends? What is the dividend yield for AstraZeneca?

AstraZeneca announced a dividend on Thursday, July 29th. Investors of record on Thursday, August 12th will be given a dividend of GBX 64.80 per share on Monday, September 13th. This represents a yield of 0.78%. The ex-dividend date of this dividend is Thursday, August 12th. The official announcement can be accessed at this link.
View AstraZeneca's dividend history.

Is AstraZeneca a good dividend stock?

AstraZeneca pays an annual dividend of GBX 2.84 per share and currently has a dividend yield of 2.32%. The dividend payout ratio of AstraZeneca is 1.35%. This payout ratio is at a healthy, sustainable level, below 75%.
View AstraZeneca's dividend history.

What price target have analysts set for AZN?

14 analysts have issued 1-year target prices for AstraZeneca's stock. Their forecasts range from GBX 6,950 to £105. On average, they expect AstraZeneca's share price to reach GBX 9,635 in the next twelve months. This suggests a possible upside of 9.9% from the stock's current price.
View analysts' price targets for AstraZeneca or view top-rated stocks among Wall Street analysts.

Who are AstraZeneca's key executives?

AstraZeneca's management team includes the following people:

• Mr. Pascal Soriot D.V.M., M.B.A., CEO & Exec. Director (Age 62, Pay $4.39M)
• Mr. Marc Dunoyer, CFO & Exec. Director (Age 69, Pay $2.45M)
• Ms. Pam P. Cheng, Exec. Vice-Pres of Operations & Information Technology (Age 50)
• Thomas Kudsk Larsen, Head of Investor Relations
• Mr. Jefrey Pott, Exec. VP of HR & Gen. Counsel
• Ms. Katarina Ageborg, Exec. VP of Sustainability & Chief Compliance Officer
• Dr. Menelas Pangalos, Exec. Vice-Pres of BioPharmaceuticals R&D
• Dr. Ruud Dobber, Exec. Vice-Pres of BioPharmaceuticals Bus. Unit
• Dr. Susan Mary Galbraith M.D., Ph.D., Exec. VP of Oncology R&D (Age 55)
• Dr. David B. Goldstein Ph.D., Chief Adviser

Who are some of AstraZeneca's key competitors?

Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer Aktiengesellschaft (BAYN), Dechra Pharmaceuticals (DPH), HUTCHMED (HCM), Vectura Group (VEC), Beximco Pharmaceuticals (BXP), Sareum (SAR), Allergy Therapeutics (AGY), Trilogy International Partners (TRL), ECO Animal Health Group (EAH), Futura Medical (FUM), Avivagen (VIV), Cathay International Holdings Limited (CTI.L) (CTI), N4 Pharma (N4P) and Antisense Therapeutics (ANP).
View all of AZN's competitors.

What other stocks do shareholders of AstraZeneca own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), NVIDIA (NVDA), Gilead Sciences (GILD), Intel (INTC), Vodafone Group (VOD), Advanced Micro Devices (AMD), Alibaba Group (BABA), Pfizer (PFE), QUALCOMM (QCOM) and The Hain Celestial Group (HAIN).

What is AstraZeneca's stock symbol?

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

How do I buy shares of AstraZeneca?

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is AstraZeneca's stock price today?

One share of AZN stock can currently be purchased for approximately GBX 8,768.

How much money does AstraZeneca make?

AstraZeneca has a market capitalization of £135.83 billion and generates £29.53 billion in revenue each year.

How many employees does AstraZeneca have?

AstraZeneca employs 76,100 workers across the globe.

What is AstraZeneca's official website?

The official website for AstraZeneca is www.astrazeneca.com.

Where are AstraZeneca's headquarters?

AstraZeneca is headquartered at 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom.

How can I contact AstraZeneca?

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.